Hybrigenics (Euronext Growth Paris – FR0004153930 – ALHYG)
publishes, in accordance with Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers, the total number of voting rights and shares comprising its share capital as of November 30, 2021.
Dated |
Total number of shares |
Total number of voting rights | |
November 30, 2021 | 253680 107 | Theoretical voting rights | 253680 107 |
Exercisable voting rights | 253680 107 |
About Hybrigenics
Hybrigenics is a biopharmaceutical company listed (ALHYG) in Paris on the Euronext Growth market of Euronext, eligible for PEA-PME.
Hybrigenics and its subsidiaries constitute the DMS Biotech division, which carries the development strategy of DMS Group (Euronext Paris – FR0012202497 – DGM) in the fields of biotechnology, oncology, regenerative medicine and anti-aging medicine. It specializes in the development of innovative technical solutions using adipose tissue cells, and particularly stem cells.
More information on www.hybrigenics.com.
Hybrigenics
is listed on the Euronext Growth market of Euronext Paris – ISIN: FR0004153930 – Ticker: ALHYG – Eligible PEA-PME
Hybrigenics Julien gauthier General manager [email protected] 09 71 04 32 63 |
This publication has the service “? Actusnews SECURITY MASTER”.
– SECURITY MASTER Key:
l5xpYZ2cZZrKlXCelMibmZaXbJxhxZKVZ2WWmWlqY5bInZ9plmuXbJzGZnBjmWVv
– To check this key:
https://www.security-master-key.com.
Regulated information:
Total number of voting rights and capital:
– Information relating to the total number of voting rights and shares making up the capital
Full and original press release in PDF format:
https://www.actusnews.com/news/72409-hybrigenics-nombre-actions-ddv-30112021.pdf
© Copyright Actusnews Wire
Receive free company updates by email by subscribing to www.actusnews.com